Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward

Complications, morbidity and mortality of nonalcoholic fatty liver disease

(2020) Alessandro Mantovani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Established and emerging factors affecting the progression of nonalcoholic fatty liver disease

(2020) Stergios Kechagias et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

(2020) Michelle T. Long et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease

(2020) Nikolaos Perakakis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Commentary: From mice to men: In search for dietary interventions to form the background on which pharmacotherapy for non-alcoholic fatty liver disease should be based

(2020) Emir Muzurović et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Of mice and men: why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?

(2019) Chrysoula Boutari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort

(2019) Amandeep Singh et al.   DIGESTIVE DISEASES AND SCIENCES

Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study

(2019) Nikolaos Perakakis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?

(2018) Stergios A. Polyzos et al.   HEPATOLOGY

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis

(2018) Alessandro Mantovani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?

(2018) Niki Katsiki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies

(2018) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)

(2018) Jian Gao Fan et al.   Journal of Digestive Diseases

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Surgical management of obesity

(2018) Jacob Nudel et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Treatment of NAFLD with diet, physical activity and exercise

(2017) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic Fatty Liver Disease

(2012) Stergios A. Polyzos et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY